Prognostic, Predictive, and POC: Biomarkers from Research to Clinic

Agenda Topics

• Cardiovascular and Metabolic Diseases
• Developing Diagnostics and Therapeutics in CNS Diseases using Biomarkers
• Examination of Prognostic versus Predictive Biomarkers
• Algorithms for Prediction and Response
• Commercial Impact and Clinical Adoption
• Current Examples in the Clinic and their Impact
• Disease Classes Addressed Currently
• Immunology Biomarkers and the Microbiome
• Oncology Biomarkers: Research to Clinical Trajectory
• Various Cancer Classes such as Breast Cancer, Colorectal Cancer, Lung Cancer, GI Cancers
• Point-of-Care Diagnostics and Mobile Point-of-Care (mPOC) Diagnostics
• Biomarkers
• Technologies for Deployment
• R&D Pipeline of Markers with Associated Therapeutics
• The Impact of Next-Generation Sequencing (NGS) on Biomarker Analysis
• Clinical Applications of RNA-Seq
• Various Classes of Biomarkers: Protein, Gene-Expression, microRNA, Epigenetic

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Rajesh Ambasudhan, Research Assistant Professor, Sanford-Burnham Medical Research Institute
Christos Argyropoulos, Assistant Professor, Division of Nephrology, University of New Mexico
David Cheresh, Distinguished Professor of Pathology , University of California-San Diego
Donald Durden, Pediatric Researcher, University Of California School Of Medicine
Denise Faustman, Director, Immunobiology Laboratory & Associate Professor of Medicine, Massachusetts General Hospital/Harvard Medical School
Anand Giddabasappa, Principal Scientist, Global Science and Technology, Pfizer
Sridhar Iyengar, Founder/Director, Misfit Wearables
Filip Janku, Associate Professor, Center Medical Director, Clinical and Translational Research Center, The University of Texas MD Anderson Cancer Center
Greg Jones, Director of Business Development and Technical Affairs, MDxHealth SA
David Kallend, Vice President, Global Medical Director, The Medicines Company
Serguei Kozlov, Leidos Biomedical Research, Inc. Principal Scientist, Center for Advancer Preclinical Research, NIH
Luke Lee, Director, Global Health Research and Technology (BIGHEART), NUS
Scott Lippman, Associate Vice Chancellor, University of California-San Diego
Terri McClanahan, Director, Profiling & Expression, Merck Biologics Discovery
William Mobley, Distinguished Professor and Chair, Department of Neurosciences, University of California-San Diego
Chamindie Punyadeera, Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology
George Zouridakis, Professor, University of Houston